Department of Defense gets $10 million raise to battle prostate cancer

Dave Pearson | | Health Imaging | Oncology Imaging

The 2017 Defense Appropriations Bill greenlighted by the Senate last week includes a $10 billion increase, to $90 billion, for the Pentagon’s prostate cancer research program.

“The funding increase means many new prostate cancer research projects this year focused on new treatments and improving diagnosis methods,” says Jamie Bearse, CEO of the group ZERO: The End of Prostate Cancer, in a press release picked up by Prostate Cancer News Today.

The outlet notes that the Pentagon’s medical research programs have led to three new treatments for prostate cancer plus a genetic diagnosis profile.

Read the rest:

Congress Adds $10M to Funding for Pentagon’s Prostate Cancer Research Program

Dave Pearson
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Related Content

Prostate cancer radiotherapy timeline can be safely shortened
New radiopharmaceutical targeted at gastrointenstinal cancers yields impressive results
New PET method combines antibody with radioactive isotope to improve lung cancer detection
VI-RADS threshold, imaging features predict bladder cancer invasiveness with nearly 100% accuracy
PHOTO GALLERY: thyroid nodule imaging
Tiny 'water bears' may hold key to reducing radiation-induced side effects

Around the web

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH.